retatrutide nejm 2023 obesity trial ly3437943 peptide Retatrutide Phase 3: TRIUMPH Program
Description
Description Retatrutide by GenPep 24 mg Pen Description Retatrutide by GenPep is a high-purity, research-grade formulation designed for ongoing studies in metabolic and peptide science
Building in targeted daily support From there, additional nutrients can help support specific areas that may benefit from additional attention when overall intake is reduced, including muscle, bone, and energy systems
, 1639%
Reduced-Frequency Maintenance (Wu, Cengiz & Lawley, 2025) A separate analysis published in Obesity examined patients taking semaglutide or tirzepatide every 24 weeks instead of weekly
KWONG: GLP-1s
